[1] |
Arakeri G, Rai KK, Hunasgi S , et al. Oral submucous fibrosis: an update on current theories of pathogenesis[J]. J Oral Pathol Med, 2017,46(6):406-412.
doi: 10.1111/jop.2017.46.issue-6
URL
|
[2] |
Caro V, Sutera FM, Giannola LI . In situ delivery of corticosteroids for treatment of oral diseases[J]. Ther Deliv, 2017,8(10):899-914.
doi: 10.4155/tde-2017-0055
URL
|
[3] |
Yang YH, Lee HY, Tung S , et al. Epidemiological survey of oral submucous fibrosis and leukoplakia in aborigines of Taiwan[J]. J Oral Pathol Med, 2001,30(4):213-219.
doi: 10.1034/j.1600-0714.2001.300404.x
URL
|
[4] |
Lee CH, Ko AMS, Warnakulasuriya S , et al. Intercountry prevalences and practices of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel-quid consortium of south and east Asia[J]. Int J Cancer, 2011,129(7):1741-1751.
doi: 10.1002/ijc.v129.7
URL
|
[5] |
Tang JG, Jian XF, Gao ML , et al. Epidemiological survey of oral submucous fibrosis in Xiangtan City, Hunan Province, China[J]. Community Dent Oral Epidemiol, 1997,25(2):177-180.
doi: 10.1111/com.1997.25.issue-2
URL
|
[6] |
Rajendran R, Raju GK, Nair SM , et al. Prevalence of oral submucous fibrosis in the high natural radiation belt of Kerala, south India[J]. Bull World Health Organ, 1992,70(6):783-789.
|
[7] |
Sirsat SM, Khanolkar VR . Submucous fibrosis of the palate in diet-preconditioned Wistar rats. Induction by local painting of capsaicin: an optical and electron microscopic study[J]. Arch Pathol, 1960,70:171-179.
|
[8] |
Sumeth Perera MW, Gunasinghe D, Perera PA , et al. Development of an in vivo mouse model to study oral submucous fibrosis[J]. J Oral Pathol Med, 2007,36(5):273-280.
doi: 10.1111/jop.2007.36.issue-5
URL
|
[9] |
Zhang SS, Gong ZJ, Xiong W , et al. A rat model of oral submucous fibrosis induced by bleomycin[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2016,122(2):216-223.
doi: 10.1016/j.oooo.2015.07.042
URL
|
[10] |
Wen QT, Wang T, Yu DH , et al. Development of a mouse model of arecoline-induced oral mucosal fibrosis[J]. Asian Pac J Trop Med, 2017,10(12):1177-1184.
doi: 10.1016/j.apjtm.2017.10.026
URL
|
[11] |
Sharma A, Kumar R, Johar N , et al. Oral submucous fibrosis: an etiological dilemma[J]. J Exp Ther Oncol, 2017,12(2):163-166.
URL
pmid: 29161786
|
[12] |
Shanbhag VK . Medical management of oral submucous fibrosis[J]. Asia Pac J Oncol Nurs, 2015,2(1):51.
doi: 10.4103/2347-5625.143766
URL
|
[13] |
Razi A, Iqbal A, ul Wahab N . Topical application of tocopherol with corticosteroid in reducing the early signs and symptoms of oral submucous fibrosis patients[J]. Annals Abbasi Shaheed Hospital Karachi Med Dent College, 2016,21(2):100-105.
|
[14] |
Utsunomiya H, Tilakaratne WM, Oshiro K , et al. Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization[J]. J Oral Pathol Med, 2005,34(8):498-507.
doi: 10.1111/jop.2005.34.issue-8
URL
|
[15] |
谢辉, 刘健, 凌天牖 . 细胞因子IL-6, TGF-β1在口腔黏膜下纤维性变中的表达[J]. 临床口腔医学杂志, 2012,28(10):592-594.
|
|
Xie H, Liu J, Ling TY . Expressions of chemokine IL-6, TGF-β1 in oral submucous fibrosis[J]. J Clin Stomatol, 2012,28(10):592-594.
|
[16] |
Zhang ZR, Chen LY, Qi HY , et al. Expression and clinical significance of periostin in oral lichen planus[J]. Exp Ther Med, 2018,15(6):5141-5147.
|
[17] |
Stoppel WL, Kaplan DL, Black LD . Electrical and mechanical stimulation of cardiac cells and tissue constructs[J]. Adv Drug Deliv Rev, 2016,96(1):135-155.
doi: 10.1016/j.addr.2015.07.009
URL
|
[18] |
王涛, 温琦涛, 于大海 , 等. 一种口腔黏膜下纤维化小鼠模型的构建方法: 中国, CN106511345A[P]. [2017-03-22].
|
|
Wang T, Wen QT, Yu DH , et al. Establishment of a mouse model of oral submucousfibrosis: China, CN106511345A[P], [2017-03-22].
|